A significant number of patients are often overlooked in healthcare systems, not because they cancel appointments, but because they never book them in the first place. These individuals may include shift workers who struggle to find time, parents who cannot take a day off, or those with stigmatized conditions who prefer to avoid in-person visits. As a result, they may only appear in the system later on, when their conditions have worsened and require emergency attention.
This phenomenon is known as the access gap, which is often attributed to the cost of accessing healthcare, including the time, distance, and effort required to see a doctor. When this cost becomes too high, patients may choose to forgo care altogether. Online prescription services and remote consultations can help alleviate this issue by reducing the friction associated with in-person visits, but they are not a solution for every problem.
Telemedicine is often misconstrued as a convenience for those who are already healthy and connected. However, it is actually those with the least flexibility in their lives who benefit the most. For example, a patient who requires a routine prescription refill or has a familiar, recurring problem may not need a physical examination to receive safe and effective care. By forcing these individuals to undergo in-person appointments, healthcare systems may inadvertently drive them away.
Chronic conditions, in particular, require continuous management, and missed refills can have serious physiological consequences. By lowering the barriers to refills, healthcare systems can improve patient outcomes and reduce the likelihood of treatment gaps. This is especially important for conditions that require ongoing management, such as hypertension or diabetes.
The COVID-19 pandemic has accelerated the adoption of telemedicine in many countries, including Poland, where electronic prescriptions have become the national standard. This has enabled patients to access their prescriptions digitally and pick them up at any pharmacy with a code. The key to this system is that the clinical encounter and prescription are decoupled from a physical location, but still involve a licensed prescriber.
It is essential to acknowledge the limitations of remote prescribing and to establish clear boundaries for its use. This approach is suitable for stable, low-risk patients who require ongoing therapy or have clearly defined conditions. However, it is not a substitute for in-person examinations when red-flag symptoms are present or when controlled substances are involved. A responsible online prescription service must be willing to refer patients to in-person care when necessary.
The debate surrounding online prescribing often devolves into a binary argument, with some viewing it as a dangerous shortcut and others seeing it as a frictionless solution. However, the reality is more nuanced. The key question is which patients and problems can benefit from reduced friction without compromising safety. For many patients with stable chronic conditions, predictable refills, or stigmatized conditions, online prescription services can improve outcomes without degrading safety.
Health systems often focus on expanding capacity, but neglect to address the friction that prevents patients from accessing care in the first place. By reducing this friction, online prescription services can make invisible patients visible again, improving outcomes and reducing the likelihood of treatment gaps. This is not a revolutionary concept, but rather a quiet correction to a long-standing issue in healthcare.
